The Board of Trustees of AMEND have allocated £30,000 for the 2020 round of Research Awards. The awards aim to supplement an existing project or pump-prime new research ideas. Applicants must be registered members of AMEND (membership is free) and the successful projects must be specifically directed to the study of neuroendocrine and endocrine tumors, within the context of the Charity’s remit.
Awards are currently only available to projects carried out within the United Kingdom and Eire. Grants are usually to the value of £10,000 each, although larger amounts have been awarded. Current awards include the following:
• The Nick Fayers Award for MEN1 Research forms part of the annual grants program. It was set up in memory of the late Nick Fayers who had MEN1
• ACC Support UK Awards may be granted for projects related to adrenocortical cancer
• AMEND General Research Award. Grants for any of the diseases and tumors under the AMEND umbrella (MEN1, MEN2A, MEN2B, ACC, MTC, SDHx and pheochromocytoma).
For more information and to apply, visit the AMEND website.
The deadline for submissions of applications is April 30th, 2020.